Closing: The Clinic Takeaway on AOD 9604 in Miami AOD 9604 is a genuinely interesting fat metabolism peptide with a modest evidence base and a clear regulatory caveat: it is not FDA-approved, and the research supports it as a possible adjunct rather than a miracle
Interestingly, they found aberrations in ROS clearance pathways, including elevated glutathione levels, decreases in mitochondrial superoxide dismutase levels, and glutathione peroxidase 4 mediated lipid oxidative damage
Automated perimetry testing revealed maintenance or improvement of visual field parameters, suggesting protection of peripheral retinal function typically lost early in retinal degenerative diseases
Shots help support recovery and sustained performance
While individual variation exists, complete absence of any effect at 4mg or higher suggests a calculation issue or a peptide potency problem
Another study explored the effects of intranasally administered epithalon on the pineal cells of stress-induced rats and normal rats, focusing on the proto-oncogene c-Fos, which plays a key role in brain development